Skip to content
Clinical Trials – home
United KingdomBack to the United Kingdom

Clinical trials in Grengegorman – page 24

334 clinical trials in Grengegorman, United Kingdom. Every trial is listed in the EU Clinical Trials Register and updated daily.

Grengegorman at a glance
334
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

334 trials in Grengegorman

Open in trial search

Study of DYNE-251 safety and effectiveness in patients with Duchenne muscular dystrophy who are candidates for exon 51 skipping treatment

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Fragment Antibody Targeting Human Tfr1 Conjugated To Phosphorodiamidate Morpholino Oligomer
  • Sponsor:Dyne Therapeutics Inc.

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Breast cancer

Not recruiting

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Breast cancer+1

Not recruiting

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG

Open angle glaucoma

Not recruiting

Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bimatoprost
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Afimetoran Besilate Dihydrate
  • Sponsor:Beeline Medicines Corp.

Study of Methylone Treatment for Adults with Post-Traumatic Stress Disorder (PTSD)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Methylone
  • Sponsor:Transcend Therapeutics Inc.

COVID-19

Not recruiting

Study on Abatacept for Improving Recovery in Hospitalized COVID-19 Patients

Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:University Of Minnesota

Major depression

Not recruiting

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine
  • Sponsor:Compass Pathfinder Limited

Clinical research in Grengegorman

What the registry says about research in the country

01 Ophthalmology Research

Innovative clinical trials focusing on treating myopia progression in pediatric patients, exploring new therapeutic approaches for vision care management.

  • Pediatric Vision Care
  • Myopia Management
  • Visual Development

Research efforts aim to evaluate novel treatments for controlling childhood nearsightedness, potentially offering new solutions for young patients struggling with progressive vision changes.

02 Pediatric Eye Care

Dedicated studies examining the effectiveness of new ophthalmic solutions in managing vision disorders among children, with a focus on long-term treatment outcomes.

  • Vision Development
  • Early Intervention
  • Treatment Safety

These trials represent significant advances in pediatric ophthalmology, investigating safe and effective interventions for young patients with progressive vision conditions.

03 Vision Science

Comprehensive research into vision disorders affecting young populations, utilizing controlled clinical studies to advance understanding and treatment options.

  • Clinical Efficacy
  • Treatment Innovation
  • Long-term Outcomes

The studies emphasize the importance of early intervention and monitoring in pediatric vision care, with potential implications for future treatment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.